UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Lymphangiogenesis in development and disease

Thrombosis and haemostasis, 2007-08, Vol.98 (2), p.304-310

2007

Volltextzugriff (PDF)

Renaissance of Radiotherapy in Intestinal Lymphoma? 10‐Year Efficacy and Tolerance in Multimodal Treatment of 134 Patients: Follow‐up of Two German Multicenter Consecutive Prospective Phase II Trials

The oncologist (Dayton, Ohio), 2020-05, Vol.25 (5), p.e816-e832

2020

Volltextzugriff (PDF)

Osteopontin is a prognostic factor for survival of acute myeloid leukemia patients

Blood, 2012-05, Vol.119 (22), p.5215-5220

2012

Volltextzugriff (PDF)

Targeting Tissue Factor to Tumor Vasculature to Induce Tumor Infarction

Cancers, 2021-06, Vol.13 (11), p.2841

2021

Volltextzugriff (PDF)

Induced lymphatic sinus hyperplasia in sentinel lymph nodes by VEGF-C as the earliest premetastatic indicator

International journal of oncology, 2012-12, Vol.41 (6), p.2073-2078

2012

Volltextzugriff (PDF)

S100A2 Induces Metastasis in Non–Small Cell Lung Cancer

Clinical cancer research, 2009-01, Vol.15 (1), p.22-29

2009

Volltextzugriff (PDF)

Tumor immune escape by the loss of homeostatic chemokine expression

Proceedings of the National Academy of Sciences - PNAS, 2007-11, Vol.104 (48), p.19055-19060

2007

Volltextzugriff (PDF)

Induction of lymphatic endothelial cell differentiation in embryoid bodies

Blood, 2006-02, Vol.107 (3), p.1214-1216

2006

Volltextzugriff (PDF)

The miR-290-295 cluster suppresses autophagic cell death of melanoma cells

Scientific reports, 2012, Vol.2 (1), p.808, Article 808

2012

Volltextzugriff (PDF)

Prognostic factors for acute myeloid leukaemia in adults – biological significance and clinical use

British journal of haematology, 2014-04, Vol.165 (1), p.17-38

2014

Volltextzugriff (PDF)

Treatment landscape, outcome and quality of life in patients with pancreatic cancer: IKF642/PARAGON study

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.4155-4155

2024

Volltextzugriff (PDF)

Final Results from RIBBIT: A Randomized Phase III Study to Evaluate Efficacy and Quality of Life in Patients with Metastatic Hormone Receptor-Positive, HER2-Negative Breast Cancer Receiving Ribociclib in Combination with Endocrine Therapy or Chemotherapy with or without Bevacizumab in the First-Line Setting

Breast care (Basel, Switzerland), 2024-02, Vol.19 (1), p.49-61

2024

Volltextzugriff (PDF)

Chemotherapy-Free Combination of Obinutuzumab and Ibrutinib in First LINE Treatment of Follicular Lymphoma. the Alternative Study By the German Low Grade Lymphoma Study Group (GLSG)

Blood, 2018-11, Vol.132 (Supplement 1), p.448-448

2018

Volltextzugriff (PDF)

Myelodysplastic syndromes (MDS) in regular care in Germany - the oldest patients come to the fore

Leukemia & lymphoma, 2018-05, Vol.59 (5), p.1244-1247

2018

Volltextzugriff (PDF)

Angiogenesis inhibition in cancer therapy: platelet-derived growth factor (PDGF) and vascular endothelial growth factor (VEGF) and their receptors: biological functions and role in malignancy

Recent results in cancer research, 2010, Vol.180, p.51

2010

Volltextzugriff (PDF)

Efficacy and Safety of the Combination of Tirabrutinib and Entospletinib With or Without Obinutuzumab in Relapsed Chronic Lymphocytic Leukemia

HemaSphere, 2022-04, Vol.6 (4), p.e692-n/a

2022

Volltextzugriff (PDF)

Analysis of a novel highly metastatic melanoma cell line identifies osteopontin as a new lymphangiogenic factor

International journal of oncology, 2012-10, Vol.41 (4), p.1455-1463

2012

Volltextzugriff (PDF)

Anticancer Therapy by Tumor Vessel Infarction with Polyethylene Glycol Conjugated Retargeted Tissue Factor

Journal of medicinal chemistry, 2013-03, Vol.56 (6), p.2337-2347

2013

Volltextzugriff (PDF)

Cardiovascular effects in adolescents while they are playing video games: A potential health risk factor?

Psychophysiology, 2008-03, Vol.45 (2), p.327-332

2008

Volltextzugriff (PDF)

1 – 25 von 46

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(43)
Buchkapitel
(3)

Sprache

Englisch
(46)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)

Lymphangiogenesis in development and disease

Renaissance of Radiotherapy in Intestinal Lymphoma? 10‐Year Efficacy and Tolerance in Multimodal Treatment of 134 Patients: Follow‐up of Two German Multicenter Consecutive Prospective Phase II Trials

Osteopontin is a prognostic factor for survival of acute myeloid leukemia patients

Targeting Tissue Factor to Tumor Vasculature to Induce Tumor Infarction

Induced lymphatic sinus hyperplasia in sentinel lymph nodes by VEGF-C as the earliest premetastatic indicator

S100A2 Induces Metastasis in Non–Small Cell Lung Cancer

Tumor immune escape by the loss of homeostatic chemokine expression

Induction of lymphatic endothelial cell differentiation in embryoid bodies

The miR-290-295 cluster suppresses autophagic cell death of melanoma cells

Prognostic factors for acute myeloid leukaemia in adults – biological significance and clinical use

Treatment landscape, outcome and quality of life in patients with pancreatic cancer: IKF642/PARAGON study

Effectiveness, safety and quality of life of trifluridine/tipiracil in pretreated patients with metastatic colorectal cancer: Real‐world data from the noninterventional TACTIC study in Germany

Organ preservation with durvalumab-based immunotherapy in combination with chemoradiation as definitive therapy for early stage, cT1, and cT2N0 esophageal adenocarcinoma with indication for radical surgery: A prospective, multicenter study of the FLOT-AIO Gastric Cancer Group (IKF-t057/PRESTO trial)

A Prospective, Open-Label, Multicenter, Phase 2 Trial to Evaluate the Safety and Efficacy of the Combination of Tirabrutinib (ONO/GS-4059) and Entospletinib with and without Obinutuzumab in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)

Polatuzumab vedotin as a salvage and bridging treatment in relapsed or refractory large B-cell lymphomas

Chemotherapy-Free Combination of Obinutuzumab and Ibrutinib in First LINE Treatment of Follicular Lymphoma. the Alternative Study By the German Low Grade Lymphoma Study Group (GLSG)

Polatuzumab Vedotin in Relapsed and Refractory (r/r) Large B-Cell Lymphoma (LBCL): Real-World Data of the German National Compassionate Use Program (CUP)

Myelodysplastic syndromes (MDS) in regular care in Germany - the oldest patients come to the fore

Angiogenesis inhibition in cancer therapy: platelet-derived growth factor (PDGF) and vascular endothelial growth factor (VEGF) and their receptors: biological functions and role in malignancy

Efficacy and Safety of the Combination of Tirabrutinib and Entospletinib With or Without Obinutuzumab in Relapsed Chronic Lymphocytic Leukemia

Analysis of a novel highly metastatic melanoma cell line identifies osteopontin as a new lymphangiogenic factor

Anticancer Therapy by Tumor Vessel Infarction with Polyethylene Glycol Conjugated Retargeted Tissue Factor

Cardiovascular effects in adolescents while they are playing video games: A potential health risk factor?

Suchergebnisse filtern